nodes	percent_of_prediction	percent_of_DWPC	metapath
Alvimopan—Urinary retention—Phenylpropanolamine—obesity	0.0177	0.0554	CcSEcCtD
Alvimopan—Urinary retention—Cimetidine—obesity	0.014	0.0439	CcSEcCtD
Alvimopan—Dyspepsia—Methamphetamine—obesity	0.0107	0.0336	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Methamphetamine—obesity	0.0105	0.0329	CcSEcCtD
Alvimopan—Constipation—Methamphetamine—obesity	0.0104	0.0326	CcSEcCtD
Alvimopan—Dyspepsia—Benzphetamine—obesity	0.0103	0.0324	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Benzphetamine—obesity	0.0101	0.0317	CcSEcCtD
Alvimopan—Constipation—Phendimetrazine—obesity	0.00914	0.0287	CcSEcCtD
Alvimopan—Flatulence—Cimetidine—obesity	0.00873	0.0274	CcSEcCtD
Alvimopan—Constipation—Phenylpropanolamine—obesity	0.00781	0.0245	CcSEcCtD
Alvimopan—Dyspepsia—Phentermine—obesity	0.00769	0.0241	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Phentermine—obesity	0.00754	0.0236	CcSEcCtD
Alvimopan—Urinary retention—Sibutramine—obesity	0.00747	0.0234	CcSEcCtD
Alvimopan—Constipation—Phentermine—obesity	0.00747	0.0234	CcSEcCtD
Alvimopan—Hypokalaemia—Orlistat—obesity	0.00739	0.0232	CcSEcCtD
Alvimopan—Hypokalaemia—Sibutramine—obesity	0.00715	0.0224	CcSEcCtD
Alvimopan—Dyspepsia—Diethylpropion—obesity	0.00669	0.021	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Diethylpropion—obesity	0.00656	0.0206	CcSEcCtD
Alvimopan—Urinary retention—Bupropion—obesity	0.00652	0.0204	CcSEcCtD
Alvimopan—Constipation—Diethylpropion—obesity	0.0065	0.0204	CcSEcCtD
Alvimopan—Constipation—Cimetidine—obesity	0.00618	0.0194	CcSEcCtD
Alvimopan—Urinary tract disorder—Orlistat—obesity	0.00555	0.0174	CcSEcCtD
Alvimopan—Urethral disorder—Orlistat—obesity	0.00551	0.0173	CcSEcCtD
Alvimopan—Indinavir—SLC22A1—obesity	0.00527	0.28	CrCbGaD
Alvimopan—Malnutrition—Orlistat—obesity	0.00489	0.0153	CcSEcCtD
Alvimopan—Flatulence—Orlistat—obesity	0.00482	0.0151	CcSEcCtD
Alvimopan—Malnutrition—Sibutramine—obesity	0.00473	0.0148	CcSEcCtD
Alvimopan—Back pain—Orlistat—obesity	0.00473	0.0148	CcSEcCtD
Alvimopan—Urinary tract disorder—Bupropion—obesity	0.00468	0.0147	CcSEcCtD
Alvimopan—Flatulence—Sibutramine—obesity	0.00466	0.0146	CcSEcCtD
Alvimopan—Connective tissue disorder—Bupropion—obesity	0.00466	0.0146	CcSEcCtD
Alvimopan—Urethral disorder—Bupropion—obesity	0.00465	0.0146	CcSEcCtD
Alvimopan—Back pain—Sibutramine—obesity	0.00458	0.0144	CcSEcCtD
Alvimopan—Anaemia—Sibutramine—obesity	0.00438	0.0137	CcSEcCtD
Alvimopan—Benazepril—MTHFR—obesity	0.00432	0.23	CrCbGaD
Alvimopan—Urinary retention—Topiramate—obesity	0.00415	0.013	CcSEcCtD
Alvimopan—Malnutrition—Bupropion—obesity	0.00413	0.0129	CcSEcCtD
Alvimopan—Flatulence—Bupropion—obesity	0.00407	0.0128	CcSEcCtD
Alvimopan—Quinapril—ACE—obesity	0.00405	0.215	CrCbGaD
Alvimopan—Back pain—Bupropion—obesity	0.00399	0.0125	CcSEcCtD
Alvimopan—Hypokalaemia—Topiramate—obesity	0.00397	0.0125	CcSEcCtD
Alvimopan—Anaemia—Bupropion—obesity	0.00381	0.012	CcSEcCtD
Alvimopan—Benazepril—ACE—obesity	0.00352	0.187	CrCbGaD
Alvimopan—Dyspepsia—Orlistat—obesity	0.00351	0.011	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Orlistat—obesity	0.00345	0.0108	CcSEcCtD
Alvimopan—Dyspepsia—Sibutramine—obesity	0.0034	0.0107	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Sibutramine—obesity	0.00334	0.0105	CcSEcCtD
Alvimopan—Constipation—Sibutramine—obesity	0.0033	0.0104	CcSEcCtD
Alvimopan—Urinary tract disorder—Topiramate—obesity	0.00298	0.00935	CcSEcCtD
Alvimopan—Connective tissue disorder—Topiramate—obesity	0.00297	0.00931	CcSEcCtD
Alvimopan—Dyspepsia—Bupropion—obesity	0.00296	0.0093	CcSEcCtD
Alvimopan—Urethral disorder—Topiramate—obesity	0.00296	0.00928	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Bupropion—obesity	0.00291	0.00912	CcSEcCtD
Alvimopan—Constipation—Bupropion—obesity	0.00288	0.00903	CcSEcCtD
Alvimopan—Malnutrition—Topiramate—obesity	0.00263	0.00824	CcSEcCtD
Alvimopan—Flatulence—Topiramate—obesity	0.00259	0.00812	CcSEcCtD
Alvimopan—Back pain—Topiramate—obesity	0.00254	0.00797	CcSEcCtD
Alvimopan—Anaemia—Topiramate—obesity	0.00243	0.00762	CcSEcCtD
Alvimopan—Dyspepsia—Topiramate—obesity	0.00189	0.00592	CcSEcCtD
Alvimopan—Gastrointestinal disorder—Topiramate—obesity	0.00185	0.00581	CcSEcCtD
Alvimopan—Constipation—Topiramate—obesity	0.00184	0.00575	CcSEcCtD
Alvimopan—Ketoprofen—PTGS2—obesity	0.000866	0.0461	CrCbGaD
Alvimopan—Ketoprofen—ALB—obesity	0.000771	0.041	CrCbGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CG—obesity	0.000116	0.000174	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PARP1—obesity	0.000114	0.000172	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GHRL—obesity	0.000114	0.000172	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—POMC—obesity	0.000114	0.000172	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRL—obesity	0.000114	0.000172	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NPY—obesity	0.000113	0.000171	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—DRD4—obesity	0.000113	0.000171	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IAPP—obesity	0.000113	0.00017	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOC3—obesity	0.000113	0.00017	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STK11—obesity	0.000112	0.000169	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—CCL2—obesity	0.000111	0.000168	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PLG—obesity	0.000111	0.000167	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—RHOA—obesity	0.000111	0.000167	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AGT—obesity	0.00011	0.000167	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—POMC—obesity	0.00011	0.000166	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—F2—obesity	0.00011	0.000166	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PRKCB—obesity	0.00011	0.000166	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AKT2—obesity	0.000109	0.000165	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CRH—obesity	0.000109	0.000165	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HTR1B—obesity	0.000109	0.000165	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PIK3R1—obesity	0.000109	0.000165	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SDC1—obesity	0.000108	0.000163	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CNR1—obesity	0.000108	0.000163	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FOXO3—obesity	0.000108	0.000163	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PRKCD—obesity	0.000108	0.000163	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ADRB2—obesity	0.000108	0.000163	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKR1C3—obesity	0.000106	0.000161	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TCF7L2—obesity	0.000106	0.00016	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SOCS1—obesity	0.000106	0.00016	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AKT2—obesity	0.000106	0.00016	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—HTR2A—obesity	0.000106	0.00016	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—C3—obesity	0.000106	0.000159	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—DRD2—obesity	0.000105	0.000159	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CD—obesity	0.000105	0.000159	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CG—obesity	0.000105	0.000158	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SOCS3—obesity	0.000105	0.000158	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GCG—obesity	0.000104	0.000158	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PTPN1—obesity	0.000104	0.000158	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NPS—obesity	0.000104	0.000157	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—GNB3—obesity	0.000103	0.000155	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—F2—obesity	0.000102	0.000154	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PRKCB—obesity	0.000102	0.000154	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HTR2C—obesity	0.000102	0.000154	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—DRD1—obesity	0.000102	0.000154	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CD—obesity	0.000102	0.000153	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—TYK2—obesity	0.000101	0.000153	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PIK3CB—obesity	0.000101	0.000152	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IGF2—obesity	0.000101	0.000152	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—RHOA—obesity	0.0001	0.000152	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AGT—obesity	0.0001	0.000151	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—GNAS—obesity	9.99e-05	0.000151	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—POMC—obesity	9.99e-05	0.000151	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRL—obesity	9.96e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3R1—obesity	9.93e-05	0.00015	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NTRK2—obesity	9.9e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB1—obesity	9.86e-05	0.000149	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STK11—obesity	9.82e-05	0.000148	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOB—obesity	9.79e-05	0.000148	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—CCL2—obesity	9.77e-05	0.000148	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CG—obesity	9.76e-05	0.000147	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PLG—obesity	9.71e-05	0.000147	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—RHOA—obesity	9.69e-05	0.000146	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PARP1—obesity	9.65e-05	0.000146	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GHRL—obesity	9.65e-05	0.000146	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AKT2—obesity	9.6e-05	0.000145	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3R1—obesity	9.59e-05	0.000145	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—DRD4—obesity	9.57e-05	0.000144	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL5—obesity	9.56e-05	0.000144	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FOXO3—obesity	9.47e-05	0.000143	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ADRB2—obesity	9.45e-05	0.000143	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—LPL—obesity	9.34e-05	0.000141	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SOCS1—obesity	9.31e-05	0.000141	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—POMC—obesity	9.29e-05	0.00014	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—FOXO1—obesity	9.28e-05	0.00014	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—F2—obesity	9.27e-05	0.00014	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PRKCB—obesity	9.27e-05	0.00014	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RPS6KB1—obesity	9.26e-05	0.00014	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CD—obesity	9.22e-05	0.000139	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SOCS3—obesity	9.19e-05	0.000139	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CB—obesity	9.17e-05	0.000138	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CNR1—obesity	9.14e-05	0.000138	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GNB3—obesity	9e-05	0.000136	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TCF7L2—obesity	8.98e-05	0.000136	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AKT2—obesity	8.93e-05	0.000135	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—DRD2—obesity	8.91e-05	0.000135	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—TYK2—obesity	8.87e-05	0.000134	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CG—obesity	8.87e-05	0.000134	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CB—obesity	8.85e-05	0.000134	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IGF2—obesity	8.84e-05	0.000133	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GCG—obesity	8.82e-05	0.000133	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PTPN1—obesity	8.82e-05	0.000133	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—RHOA—obesity	8.8e-05	0.000133	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—GNAS—obesity	8.76e-05	0.000132	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3R1—obesity	8.71e-05	0.000132	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCD—obesity	8.61e-05	0.00013	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CD—obesity	8.58e-05	0.00013	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOB—obesity	8.58e-05	0.00013	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—POMC—obesity	8.44e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—HTR2A—obesity	8.42e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRL—obesity	8.42e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—C3—obesity	8.41e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL5—obesity	8.38e-05	0.000127	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STK11—obesity	8.3e-05	0.000125	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—CCL2—obesity	8.26e-05	0.000125	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PLG—obesity	8.2e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—LPL—obesity	8.19e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—RHOA—obesity	8.19e-05	0.000124	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—FOXO1—obesity	8.13e-05	0.000123	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RPS6KB1—obesity	8.12e-05	0.000123	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AKT2—obesity	8.11e-05	0.000123	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3R1—obesity	8.11e-05	0.000122	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CB—obesity	8.04e-05	0.000121	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FOXO3—obesity	8.01e-05	0.000121	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IRS2—obesity	8e-05	0.000121	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AGT—obesity	7.99e-05	0.000121	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ADRB2—obesity	7.99e-05	0.000121	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SOCS1—obesity	7.86e-05	0.000119	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—LEP—obesity	7.83e-05	0.000118	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOE—obesity	7.83e-05	0.000118	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CD—obesity	7.79e-05	0.000118	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SOCS3—obesity	7.77e-05	0.000117	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CAV1—obesity	7.76e-05	0.000117	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—APOA1—obesity	7.74e-05	0.000117	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GNB3—obesity	7.61e-05	0.000115	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCD—obesity	7.55e-05	0.000114	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—TYK2—obesity	7.5e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CB—obesity	7.48e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—ESR1—obesity	7.48e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IGF2—obesity	7.47e-05	0.000113	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—RHOA—obesity	7.44e-05	0.000112	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—GNAS—obesity	7.41e-05	0.000112	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—HTR2A—obesity	7.39e-05	0.000112	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PRKCB—obesity	7.39e-05	0.000112	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—F2—obesity	7.39e-05	0.000112	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—C3—obesity	7.38e-05	0.000111	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3R1—obesity	7.36e-05	0.000111	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—BAD—obesity	7.3e-05	0.00011	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOB—obesity	7.25e-05	0.000109	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL5—obesity	7.08e-05	0.000107	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CG—obesity	7.07e-05	0.000107	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IRS2—obesity	7.02e-05	0.000106	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AGT—obesity	7.01e-05	0.000106	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IRS1—obesity	6.99e-05	0.000105	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—LPL—obesity	6.92e-05	0.000105	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—FOXO1—obesity	6.87e-05	0.000104	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOE—obesity	6.87e-05	0.000104	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—LEP—obesity	6.87e-05	0.000104	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RPS6KB1—obesity	6.86e-05	0.000104	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CAV1—obesity	6.8e-05	0.000103	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CB—obesity	6.79e-05	0.000103	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—APOA1—obesity	6.79e-05	0.000103	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—POMC—obesity	6.73e-05	0.000102	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—INS—obesity	6.69e-05	0.000101	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—CCL2—obesity	6.58e-05	9.94e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—ESR1—obesity	6.56e-05	9.9e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PRKCB—obesity	6.48e-05	9.78e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—F2—obesity	6.48e-05	9.78e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IGF1—obesity	6.47e-05	9.77e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AKT2—obesity	6.47e-05	9.76e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—BAD—obesity	6.4e-05	9.66e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCD—obesity	6.38e-05	9.63e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—HTR2A—obesity	6.24e-05	9.43e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—C3—obesity	6.23e-05	9.41e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CD—obesity	6.21e-05	9.38e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CG—obesity	6.2e-05	9.36e-05	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—PIK3CA—obesity	6.15e-05	9.29e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—SERPINE1—obesity	6.15e-05	9.28e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IRS1—obesity	6.13e-05	9.25e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TYK2—obesity	5.98e-05	9.03e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IRS2—obesity	5.93e-05	8.96e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—RHOA—obesity	5.93e-05	8.95e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AGT—obesity	5.92e-05	8.94e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—POMC—obesity	5.9e-05	8.91e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—NOS3—obesity	5.87e-05	8.86e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3R1—obesity	5.87e-05	8.86e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—INS—obesity	5.87e-05	8.86e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—LEP—obesity	5.8e-05	8.76e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOE—obesity	5.8e-05	8.76e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—CCL2—obesity	5.77e-05	8.72e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CAV1—obesity	5.75e-05	8.68e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—APOA1—obesity	5.74e-05	8.66e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IGF1—obesity	5.67e-05	8.57e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AKT2—obesity	5.67e-05	8.56e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—PIK3CA—obesity	5.59e-05	8.44e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—ESR1—obesity	5.54e-05	8.37e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—F2—obesity	5.47e-05	8.26e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PRKCB—obesity	5.47e-05	8.26e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CD—obesity	5.45e-05	8.23e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CB—obesity	5.42e-05	8.18e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MTOR—obesity	5.42e-05	8.18e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—BAD—obesity	5.41e-05	8.17e-05	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—PIK3CA—obesity	5.4e-05	8.15e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—SERPINE1—obesity	5.39e-05	8.14e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TYK2—obesity	5.24e-05	7.91e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CG—obesity	5.24e-05	7.91e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—RHOA—obesity	5.2e-05	7.85e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IRS1—obesity	5.18e-05	7.82e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—NOS3—obesity	5.14e-05	7.77e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3R1—obesity	5.14e-05	7.77e-05	CbGpPWpGaD
Alvimopan—OPRD1—GPCR downstream signaling—AKT1—obesity	5.03e-05	7.59e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—POMC—obesity	4.99e-05	7.53e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—INS—obesity	4.96e-05	7.49e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—IL6—obesity	4.95e-05	7.47e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—PIK3CA—obesity	4.9e-05	7.4e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—CCL2—obesity	4.88e-05	7.37e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IGF1—obesity	4.8e-05	7.24e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKT2—obesity	4.79e-05	7.24e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MTOR—obesity	4.75e-05	7.17e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CB—obesity	4.75e-05	7.17e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MMP9—obesity	4.71e-05	7.11e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CD—obesity	4.6e-05	6.95e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MAPK8—obesity	4.58e-05	6.91e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling by GPCR—AKT1—obesity	4.57e-05	6.89e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—PIK3CA—obesity	4.56e-05	6.89e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—SERPINE1—obesity	4.55e-05	6.88e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TYK2—obesity	4.43e-05	6.69e-05	CbGpPWpGaD
Alvimopan—OPRK1—GPCR downstream signaling—AKT1—obesity	4.41e-05	6.66e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—RHOA—obesity	4.39e-05	6.63e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—NOS3—obesity	4.35e-05	6.57e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3R1—obesity	4.35e-05	6.57e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—IL6—obesity	4.34e-05	6.55e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—STAT3—obesity	4.19e-05	6.32e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—PIK3CA—obesity	4.14e-05	6.25e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MMP9—obesity	4.13e-05	6.23e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MAPK8—obesity	4.01e-05	6.06e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CB—obesity	4.01e-05	6.06e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MTOR—obesity	4.01e-05	6.06e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling by GPCR—AKT1—obesity	4e-05	6.05e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—MYC—obesity	3.89e-05	5.87e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—TGFB1—obesity	3.88e-05	5.86e-05	CbGpPWpGaD
Alvimopan—OPRM1—GPCR downstream signaling—AKT1—obesity	3.73e-05	5.63e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—STAT3—obesity	3.67e-05	5.54e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—IL6—obesity	3.67e-05	5.54e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MMP9—obesity	3.49e-05	5.27e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—MYC—obesity	3.41e-05	5.15e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—TGFB1—obesity	3.4e-05	5.14e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MAPK8—obesity	3.39e-05	5.12e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling by GPCR—AKT1—obesity	3.38e-05	5.11e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—PIK3CA—obesity	3.3e-05	4.99e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—STAT3—obesity	3.1e-05	4.68e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—IL6—obesity	2.92e-05	4.41e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—PIK3CA—obesity	2.89e-05	4.37e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—MYC—obesity	2.88e-05	4.35e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—TGFB1—obesity	2.88e-05	4.34e-05	CbGpPWpGaD
Alvimopan—OPRD1—Signaling Pathways—AKT1—obesity	2.7e-05	4.07e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—IL6—obesity	2.56e-05	3.87e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—PIK3CA—obesity	2.45e-05	3.69e-05	CbGpPWpGaD
Alvimopan—OPRK1—Signaling Pathways—AKT1—obesity	2.36e-05	3.57e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—IL6—obesity	2.17e-05	3.27e-05	CbGpPWpGaD
Alvimopan—OPRM1—Signaling Pathways—AKT1—obesity	2e-05	3.02e-05	CbGpPWpGaD
